Suberoylanilide hydroxamic acid (SAHA) can enhance the sensitivity and apoptosis of NB cells to chemotherapeutics by inhibiting TXNDC17, ultimately decreasing autophagy‐mediated chemoresistance. The gene discussed is TXNDC17; the disease is neuroblastoma.